196 related articles for article (PubMed ID: 27482641)
1. MYOPIC CHOROIDAL NEOVASCULARIZATION: Diagnosis and Treatment.
Lai TY; Cheung CM
Retina; 2016 Sep; 36(9):1614-21. PubMed ID: 27482641
[TBL] [Abstract][Full Text] [Related]
2. CORRESPONDENCE OF LEAKAGE ON FLUORESCEIN ANGIOGRAPHY AND OPTICAL COHERENCE TOMOGRAPHY PARAMETERS IN DIAGNOSIS AND MONITORING OF MYOPIC CHOROIDAL NEOVASCULARIZATION TREATED WITH BEVACIZUMAB.
Battaglia Parodi M; Iacono P; Bandello F
Retina; 2016 Jan; 36(1):104-9. PubMed ID: 26166803
[TBL] [Abstract][Full Text] [Related]
3. Structural and optical coherence tomography angiography in myopic choroidal neovascularization: Agreement with conventional fluorescein angiography.
Iacono P; Giorno P; Varano M; Parravano M
Eur J Ophthalmol; 2021 Jan; 31(1):149-157. PubMed ID: 31619075
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal bevacizumab for choroidal neovascularization attributable to pathological myopia: one-year results.
Ikuno Y; Sayanagi K; Soga K; Sawa M; Tsujikawa M; Gomi F; Tano Y
Am J Ophthalmol; 2009 Jan; 147(1):94-100.e1. PubMed ID: 18774550
[TBL] [Abstract][Full Text] [Related]
5. Using optical coherence tomography angiography to guide myopic choroidal neovascularization treatment: a 3-year follow-up study.
Ueda-Consolvo T; Shibuya N; Oiwake T; Abe S; Numata A; Honda Y; Yanagisawa S; Hayashi A
Graefes Arch Clin Exp Ophthalmol; 2021 Nov; 259(11):3295-3303. PubMed ID: 34142188
[TBL] [Abstract][Full Text] [Related]
6. PREDICTING LESION SHRINKAGE IN EYES WITH MYOPIC CHOROIDAL NEOVASCULARIZATION FROM FEATURES ON OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.
Liu J; Song S; Yu X
Retina; 2022 Sep; 42(9):1665-1672. PubMed ID: 35594547
[TBL] [Abstract][Full Text] [Related]
7. Comparison of visual prognoses between natural course of simple hemorrhage and choroidal neovascularization treated with intravitreal bevacizumab in highly myopic eyes: a 1-year follow-up.
Goto S; Sayanagi K; Ikuno Y; Jo Y; Gomi F; Nishida K
Retina; 2015 Mar; 35(3):429-34. PubMed ID: 25166271
[TBL] [Abstract][Full Text] [Related]
8. Microvasculature Changes of Myopic Choroidal Neovascularization and the Predictive Value of Feeder Vessel Disappearance after Ranibizumab Treatment Revealed Using Optical Coherence Tomography Angiography.
Giorno P; Iacono P; Scarinci F; Di Renzo A; Varano M; Parravano M
Ophthalmologica; 2020; 243(4):263-270. PubMed ID: 31838464
[TBL] [Abstract][Full Text] [Related]
9. Fluorescein angiography and spectral-domain optical coherence tomography for monitoring anti-VEGF therapy in myopic choroidal neovascularization.
Iacono P; Battaglia Parodi M; Papayannis A; Kontadakis S; Da Pozzo S; Cascavilla ML; La Spina C; Varano M; Bandello F
Ophthalmic Res; 2014; 52(1):25-31. PubMed ID: 24861045
[TBL] [Abstract][Full Text] [Related]
10. A new treatment algorithm for the management of myopic choroidal neovascularization using intravitreal ranibizumab.
Iacono P; Parodi MB; Papayannis A; La Spina C; Varano M; Bandello F
Acta Ophthalmol; 2015 Sep; 93(6):e519-20. PubMed ID: 25828793
[No Abstract] [Full Text] [Related]
11. Concurrent management of myopic choroidal neovascularization and rhegmatogenous retinal detachment with intravitreal antivascular endothelial growth factor during primary retinal detachment repair.
Saurabh K; Roy R; Thomas NR; Chowdhury M
Indian J Ophthalmol; 2018 Mar; 66(3):472-474. PubMed ID: 29480274
[TBL] [Abstract][Full Text] [Related]
12. The role of anti-VEGF agents in myopic choroidal neovascularization: Current standards and future outlook.
Munk MR; Rückert R; Zinkernagel M; Ebneter A; Wolf S
Expert Opin Biol Ther; 2016; 16(4):477-87. PubMed ID: 26666589
[TBL] [Abstract][Full Text] [Related]
13. Central retinal sensitivity after intravitreal injection of bevacizumab for myopic choroidal neovascularization.
Yodoi Y; Tsujikawa A; Nakanishi H; Otani A; Tamura H; Ojima Y; Hayashi H; Yoshimura N
Am J Ophthalmol; 2009 May; 147(5):816-24, 824.e1. PubMed ID: 19211092
[TBL] [Abstract][Full Text] [Related]
14. Spectral-Domain Optical Coherence Tomography of Subretinal Hyperreflective Exudation in Myopic Choroidal Neovascularization.
Bruyère E; Caillaux V; Cohen SY; Martiano D; Ores R; Puche N; Souied EH
Am J Ophthalmol; 2015 Oct; 160(4):749-58.e1. PubMed ID: 26164828
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes of anti-vascular endothelial growth factor therapy with and without posterior scleral reinforcement on myopic maculopathy in myopic choroidal neovascularization eyes.
Kang MT; Wang N; Xu W; Yusufu M; Liu W; Tian J; Qi Y
BMC Ophthalmol; 2024 Mar; 24(1):118. PubMed ID: 38481176
[TBL] [Abstract][Full Text] [Related]
16. Anti-VEGF Therapy in Myopic CNV.
Toto L; Di Antonio L; Costantino O; Mastropasqua R
Curr Drug Targets; 2021; 22(9):1054-1063. PubMed ID: 33511955
[TBL] [Abstract][Full Text] [Related]
17. Current Management of Polypoidal Choroidal Vasculopathy.
Tan CS; Lim TH; Hariprasad SM
Ophthalmic Surg Lasers Imaging Retina; 2015 Sep; 46(8):786-91. PubMed ID: 26431293
[No Abstract] [Full Text] [Related]
18. Three versus one intravitreal bevacizumab injections as initial protocol to treat myopic choroidal neovascularization.
Ruiz-Moreno JM; Montero JA; Arias L; Araiz J; Gomez-Ulla F; Silva R; Piñero DP
Acta Ophthalmol; 2012 Feb; 90(1):e82-3. PubMed ID: 21470378
[No Abstract] [Full Text] [Related]
19. Choroidal neovascularization secondary to pathological myopia-macular Bruch membrane defects as prognostic factor to anti-VEGF treatment.
Coelho J; Ferreira A; Abreu AC; Monteiro S; Furtado MJ; Gomes M; Lume M
Graefes Arch Clin Exp Ophthalmol; 2021 Sep; 259(9):2679-2686. PubMed ID: 33744983
[TBL] [Abstract][Full Text] [Related]
20. Associations of inflammatory cytokines with choroidal neovascularization in highly myopic eyes.
Yamamoto Y; Miyazaki D; Sasaki S; Miyake K; Kaneda S; Ikeda Y; Baba T; Yamasaki A; Noguchi Y; Inoue Y
Retina; 2015 Feb; 35(2):344-50. PubMed ID: 25289657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
